TY - JOUR T1 - False positives in reverse transcription PCR testing for SARS-CoV-2 JF - medRxiv DO - 10.1101/2020.04.26.20080911 SP - 2020.04.26.20080911 AU - Andrew N. Cohen AU - Bruce Kessel Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/20/2020.04.26.20080911.abstract N2 - Large-scale testing for SARS-CoV-2 by the reverse transcription polymerase chain reaction is a key part of the response to the COVID-19 pandemic, but little attention has been paid to the potential frequency and impacts of false positive results. In the absence of data on the clinical specificity of SARS-CoV-2 assays, we estimate a conservative false positive rate from external quality assessments of similar viral assays, and show that this rate may have large impacts on the reliability of positive test results. This has clinical and case management implications, affects an array of epidemiological statistics, and should inform the scale of testing and the allocation of testing resources. Measures to raise awareness of false positives, reduce their frequency, and mitigate their effects should be considered.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe was no funding for this research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are included in the text or supplementary materail. ER -